Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A4

    
• • ·Information for Readers

    Page :A5

    

• Editorial

  • ·Insights from cardiac imaging after ST-elevation myocardial infarction: Will increased recognition of patients at risk translate into improved long-term outcomes?

    Page :113-116

    Matthew R. Summers, Venu Menon

    

• Curriculum in Cardiology

  • ·Association between periodontitis and arterial hypertension: A systematic review and meta-analysis

    Page :98-112

    Rodrigo Martin-Cabezas, Narendra Seelam, Catherine Petit, Kévimy Agossa, Sébastien Gaertner, Henri Tenenbaum, Jean-Luc Davideau, Olivier Huck

    Résumé Résumé Plan Plan  

• Progress in Cardiology

  • ·Physiological mechanisms of pulmonary hypertension

    Page :1-11

    David H. MacIver, Ismail Adeniran, Iain R. MacIver, Alistair Revell, Henggui Zhang

    Résumé Résumé Plan Plan   
  • ·Cholesterol efflux capacity: An introduction for clinicians

    Page :54-63

    Malcolm Anastasius, Maaike Kockx, Wendy Jessup, David Sullivan, Kerry-Anne Rye, Leonard Kritharides

    Résumé Résumé Plan Plan  

• Trial Designs

  • ·Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)

    Page :12-21

    Khaldoun G. Tarakji, Suneet Mittal, Charles Kennergren, Ralph Corey, Jeanne Poole, Kurt Stromberg, Daniel R. Lexcen, Bruce L. Wilkoff

    Résumé Résumé Plan Plan
  • ·Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction

    Page :22-28

    C. Michael Gibson, Serge Korjian, Pierluigi Tricoci, Yazan Daaboul, John H. Alexander, Philippe G. Steg, A. Michael Lincoff, John J.P. Kastelein, Roxana Mehran, Denise D'Andrea, Bela Merkely, Maciej Zarebinski, Ton Oude Ophius, Robert A. Harrington

    Résumé Résumé Plan Plan   
  • ·Coronary angiography after cardiac arrest: Rationale and design of the COACT trial

    Page :39-45

    Jorrit S. Lemkes, Gladys N. Janssens, Heleen M. Oudemans-van Straaten, Paul W. Elbers, Nina W. van der Hoeven, Jan G.P. Tijssen, Luuk C. Otterspoor, Michiel Voskuil, Joris J. van der Heijden, Martijn Meuwissen, Tom A. Rijpstra, Georgios J. Vlachojannis, Raoul M. van der Vleugel, Koen Nieman, Lucia S.D. Jewbali, Gabe B. Bleeker, Rémon Baak, Bert Beishuizen, Martin G. Stoel, Pim van der Harst, Cyril Camaro, José P.S. Henriques, Maarten A. Vink, Marcel T.M. Gosselink, Hans A. Bosker, Harry J.G.M. Crijns, Niels van Royen, On behalf of the COACT investigators

    Résumé Résumé Plan Plan  
  • ·Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial

    Page :90-97

    Niteesh K. Choudhry, Thomas Isaac, Julie C. Lauffenburger, Chandrasekar Gopalakrishnan, Nazleen F. Khan, Marianne Lee, Amy Vachon, Tanya L. Iliadis, Whitney Hollands, Scott Doheny, Sandra Elman, Jacqueline M. Kraft, Samrah Naseem, Joshua J. Gagne, Cynthia A. Jackevicius, Michael A. Fischer, Daniel H. Solomon, Thomas D. Sequist

    Résumé Résumé Plan Plan   

• Clinical Investigations

  • ·Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: A multicenter prospective study

    Page :29-38

    Zhennan Li, Zhihui Hou, Weihua Yin, Kun Liu, Yang Gao, Haiyan Xu, Fangfang Yu, Zhanhong Ma, Wei Yu, Li Yang, Bin Lu

    Résumé Résumé Plan Plan  
  • ·Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study

    Page :46-53

    Takeki Suzuki, Sunil K. Agarwal, Rajat Deo, Nona Sotoodehnia, Morgan E. Grams, Elizabeth Selvin, Hugh Calkins, Wayne Rosamond, Gordon Tomaselli, Josef Coresh, Kunihiro Matsushita

    Résumé Résumé Plan Plan   
  • ·Exploring cognitive bias in destination therapy left ventricular assist device decision making: A retrospective qualitative framework analysis

    Page :64-73

    Molly Magid, Colleen K. McIlvennan, Jaqueline Jones, Carolyn T. Nowels, Larry A. Allen, Jocelyn S. Thompson, Dan Matlock

    Résumé Résumé Plan Plan
  • ·The effect of high-risk ST elevation myocardial infarction transfer patients on risk-adjusted in-hospital mortality: A report from the American Heart Association Mission: Lifeline program

    Page :74-81

    Michael C. Kontos, Tracy Y. Wang, Anita Y. Chen, Eric R. Bates, Harold L. Dauerman, Timothy D. Henry, Steven V. Manoukian, Matthew T. Roe, Robert Suter, Laine Thomas, William J. French

    Résumé Résumé Plan Plan   
  • ·Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudy

    Page :82-89

    Steven Sra, Mary K. Tan, Shamir R. Mehta, Harold N. Fisher, Jean-Pierre Déry, Robert C. Welsh, Mark J. Eisenberg, Christopher B. Overgaard, Barry F. Rose, Anthony J. Della Siega, Asim N. Cheema, Brian Y.L. Wong, Mark A. Henderson, Sohrab Lutchmedial, Shahar Lavi, Shaun G. Goodman, Andrew T. Yan, for the Canadian Observational AntiPlatelet sTudy (COAPT) Investigators

    Résumé Résumé Plan Plan  
  • ·Adverse diastolic remodeling after reperfused ST-elevation myocardial infarction: An important prognostic indicator

    Page :117-127

    Tuan L. Nguyen, Justin Phan, Jarred Hogan, Leia Hee, Daniel Moses, James Otton, Upul Premawardhana, Rohan Rajaratnam, Craig P. Juergens, Hany Dimitri, John K. French, David Richards, Liza Thomas

    Résumé Résumé Plan Plan   

• Letter to the Editors

  • ·Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications

    Page :e1

    Kintur Sanghvi, Allen McGrew, Kiran Hegde

     
  • ·Reply to letter to the editor by Kintur Sanghvi, MD; Allen McGrew, DO; and Kiran Hegde, BE, MBA

    Page :e3

    David A. Kandzari, Julie Trudel, SPYRAL HTN Clinical Investigators, and the Medtronic Spyral Core Development Team

     
  • ·The narrative review on morphine in acute coronary syndrome: Recognizing opioidergic cardioprotection

    Page :e5

    Xiulu Ruan, Srinivas Chiravuri, Alan D. Kaye

    Plan Plan
  • ·The narrative review on morphine in acute coronary syndrome: Recognizing opioidergic cardioprotection—reply

    Page :e7

    Cian P. McCarthy, John W. McEvoy